January 15, 2013—Discharge Documentation For Warfarin Therapy
When ordering warfarin for discharge to treat deep vein thrombosis (DVT) or pulmonary embolus (PE), providers are now required to document the use of overlap therapy, both during the inpatient stay and for discharge.
Key features:
Questions regarding overlap therapy are included in the anticoagulation agent data prompt, which is triggered when discharge orders include warfarin
The questions on overlap therapy must be answered if the reasons for ordering warfarin include deep vein thrombosis (DVT) or pulmonary embolus (PE)
Questions include the use of overlap therapy during the hospital visit, its duration if used, and whether the therapeutic goal (INR =>2) was achieved; whether overlap therapy is included in the discharge orders, and if not, why.
Instructions:
See also: